Source: PRcom

Press Release: LayerBio : LayerBio to Present Preclinical Results for Extended Release Glaucoma Formulation at ARVO

LayerBio will present preclinical study results at the Association for Research in Vision and Ophthalmology in Honolulu, Hawaii on Monday, April 30. These results demonstrate the therapeutic potential of its novel extended-release travoprost formulation using LayerBio's proprietary PolyNet delivery technology. [PR.com]

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Kenneth J. Mandell's photo - President & CEO of LayerBio

President & CEO

Kenneth J. Mandell

CEO Approval Rating

87/100

Read more